Latest AI and machine learning research in skin cancer for healthcare professionals.
BACKGROUND: Glioblastoma (GBM) is the most common malignant glioma in adults. It has an extremely po...
BACKGROUND: R-loops regulate genome stability and transcription, but their roles in uveal melanoma (...
PURPOSE: To investigate the prognostic value of an artificial intelligence (AI)-based semi-automated...
The gut microbiota appears to play a critical role in modulating antitumor immune responses and infl...
Cancer immunotherapy has revolutionised oncology by utilising immune-mediated mechanisms to achieve ...
BACKGROUND: Artificial intelligence technology is being widely developed in dermatology. However, th...
INTRODUCTION: Readily available predictive biomarkers for immune checkpoint inhibitor (ICI) response...
Cancer immunotherapy targeting the PD-1/PD-L1 pathway has transformed modern oncology; however, deve...
BACKGROUND: Cell-cell communication (CCC) mediated by ligand-receptor (L-R) interactions is fundamen...
BACKGROUND: Predicting pathological response to neoadjuvant chemotherapy combined with immunotherapy...
The identification of reliable predictors for immunotherapy response remains a critical challenge in...
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous malignancy with ...
PURPOSE: Radiation pneumonitis (RP) is a dose-limiting toxicity in lung cancer radiotherapy, often p...
BACKGROUND: Cancer is a leading cause of death in both the USA and India. During Prime Minister Nare...
Inherited genetic variation can weaken the ability of the immune system to detect and eliminate mali...
Immune checkpoint inhibitors (ICIs) represent a class of novel anticancer agents that enhance T cell...
Among adoptive immune cell therapies, cytokine-induced killer cell (CIK) therapy has demonstrated cl...
Per- and polyfluoroalkyl substances (PFAS) are persistent pollutants linked to breast cancer (BC), b...
Biomarker research for cancer diagnosis and prognosis has rapidly expanded technologically and thema...
BACKGROUND: Advanced and recurrent cervical cancer (CC) remains a clinical challenge due to limited ...
BACKGROUND: Melanoma is the fifth most common cancer in the USA and the UK, with global incidence on...